Trial Profile
Clinical Trials Insight: 700048971
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2009
Price :
$35
*
At a glance
- Drugs Amoxapine/prednisolone (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Zalicus